What is a stock summary page? Click here for an overview.
Business Description
SMS Pharmaceuticals Ltd
ISIN : INE812G01025
Compare
Compare
Traded in other countries / regions
532815.India IPO Date
2007-02-28Description
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients (API's), and their intermediates viz. Metal Acetylacetonates, Diltiazem Hydrochloride and Taxol C-13 Side Chain. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | 2.08 | |||||
| Interest Coverage | 5.39 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.43 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -7.3 | |||||
| 3-Year FCF Growth Rate | 67.9 | |||||
| 3-Year Book Growth Rate | 9.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.51 | |||||
| 9-Day RSI | 73.62 | |||||
| 14-Day RSI | 67.15 | |||||
| 3-1 Month Momentum % | 6.36 | |||||
| 6-1 Month Momentum % | -25.8 | |||||
| 12-1 Month Momentum % | 2.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | |||||
| Quick Ratio | 0.71 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 188.77 | |||||
| Days Sales Outstanding | 94.51 | |||||
| Days Payable | 120.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.17 | |||||
| Dividend Payout Ratio | 0.05 | |||||
| Forward Dividend Yield % | 0.17 | |||||
| 5-Year Yield-on-Cost % | 0.17 | |||||
| Shareholder Yield % | -0.66 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.5 | |||||
| Operating Margin % | 12.65 | |||||
| Net Margin % | 8.5 | |||||
| FCF Margin % | -0.26 | |||||
| ROE % | 12.56 | |||||
| ROA % | 6.3 | |||||
| ROIC % | 8.72 | |||||
| 3-Year ROIIC % | -1.94 | |||||
| ROC (Joel Greenblatt) % | 13.13 | |||||
| ROCE % | 14.85 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.56 | |||||
| PE Ratio without NRI | 30.57 | |||||
| Shiller PE Ratio | 37.93 | |||||
| PEG Ratio | 76.5 | |||||
| PS Ratio | 2.6 | |||||
| PB Ratio | 3.59 | |||||
| Price-to-Tangible-Book | 3.61 | |||||
| Price-to-Operating-Cash-Flow | 40.35 | |||||
| EV-to-EBIT | 23.09 | |||||
| EV-to-EBITDA | 17.44 | |||||
| EV-to-Revenue | 3.08 | |||||
| EV-to-FCF | -1171.17 | |||||
| Price-to-GF-Value | 1.44 | |||||
| Price-to-Projected-FCF | 5.02 | |||||
| Price-to-Median-PS-Value | 1.56 | |||||
| Price-to-Graham-Number | 2.34 | |||||
| Price-to-Net-Current-Asset-Value | 187.9 | |||||
| Earnings Yield (Greenblatt) % | 4.34 | |||||
| FCF Yield % | -0.1 | |||||
| Forward Rate of Return (Yacktman) % | 2.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMS Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,775.439 | ||
| EPS (TTM) (₹) | 7.82 | ||
| Beta | 1.4 | ||
| 3-Year Sharpe Ratio | 0.64 | ||
| 3-Year Sortino Ratio | 1.27 | ||
| Volatility % | 55.21 | ||
| 14-Day RSI | 67.15 | ||
| 14-Day ATR (₹) | 10.201185 | ||
| 20-Day SMA (₹) | 216.9415 | ||
| 12-1 Month Momentum % | 2.47 | ||
| 52-Week Range (₹) | 175.25 - 398 | ||
| Shares Outstanding (Mil) | 88.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMS Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMS Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMS Pharmaceuticals Ltd Frequently Asked Questions
What is SMS Pharmaceuticals Ltd(NSE:SMSPHARMA)'s stock price today?
The current price of NSE:SMSPHARMA is ₹240.24. The 52 week high of NSE:SMSPHARMA is ₹398.00 and 52 week low is ₹175.25.
When is next earnings date of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA)?
The next earnings date of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is .
Does SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) pay dividends? If so, how much?
The Dividend Yield %  of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is 0.17% (As of Today), Highest Dividend Payout Ratio of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) was 0.13. The lowest was 0.04. And the median was 0.05. The  Forward Dividend Yield % of SMS Pharmaceuticals Ltd(NSE:SMSPHARMA) is 0.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers